Published in J Exp Med on August 29, 1997
Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33
A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med (2002) 2.34
Inflammation induces hemorrhage in thrombocytopenia. Blood (2008) 2.28
Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol (2007) 2.25
Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med (1999) 2.23
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest (2002) 2.11
Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol (1999) 2.11
Peanuts can contribute to anaphylactic shock by activating complement. J Allergy Clin Immunol (2009) 1.84
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J Clin Invest (2013) 1.77
The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem (2009) 1.73
Complement and systemic lupus erythematosus. Arthritis Res (2002) 1.58
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice. Kidney Int (2012) 1.52
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest (2006) 1.51
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood (2007) 1.49
Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med (2002) 1.39
A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am J Pathol (2001) 1.36
Functions of C5a receptors. J Mol Med (Berl) (2009) 1.10
Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med (1998) 1.08
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood (2009) 1.01
Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction. Am J Pathol (2009) 0.97
Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation. J Biol Chem (2008) 0.96
The role of the complement and the Fc gamma R system in the pathogenesis of arthritis. Arthritis Res Ther (2005) 0.95
Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol (2008) 0.95
C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol (2002) 0.94
Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition. Am J Pathol (2003) 0.93
Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs. Shock (2009) 0.87
Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin. PLoS One (2012) 0.85
Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist. Br J Pharmacol (2001) 0.85
Impaired neutrophil migration associated with specific bovine CXCR2 genotypes. Infect Immun (2005) 0.82
Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice. Mol Cell Biol (2000) 0.81
Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice. J Immunol (2014) 0.80
Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction. Am J Pathol (2009) 0.78
A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats. Influenza Other Respir Viruses (2013) 0.78
Involvement of gaseous low molecular monoxides in the cutaneous reverse passive Arthus reaction: cytoprotective action of carbon monoxide. Clin Exp Immunol (2008) 0.77
Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus. Mediators Inflamm (2016) 0.75
Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit. Br J Pharmacol (1999) 0.75
The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activation. Auto Immun Highlights (2016) 0.75
Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors. PLoS One (2016) 0.75
RP S19 C-terminal peptide trimer acts as a C5a receptor antagonist. Biochem Biophys Rep (2016) 0.75
Complement C5a Receptor is the Key Initiator of Neutrophil Adhesion Igniting Immune Complex-induced Arthritis. Sci Immunol (2017) 0.75
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol (1982) 10.99
FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell (1994) 7.66
Interleukin-6 in biology and medicine. Adv Immunol (1993) 4.06
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity (1996) 2.96
Fc receptors: rubor redux. Cell (1994) 2.77
Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology (1975) 2.62
C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol (1994) 2.57
Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol (1985) 2.31
Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science (1994) 2.18
Neurogenic amplification of immune complex inflammation. Science (1996) 2.05
Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med (1996) 1.83
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67
Lung and dermal vascular injury produced by preformed immune complexes. Am Rev Respir Dis (1978) 1.64
Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science (1992) 1.62
C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol (1987) 1.41
Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol (1994) 1.28
The pulmonary response of C5 sufficient and deficient mice to immune complexes. Am Rev Respir Dis (1981) 1.26
Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest (1995) 1.23
Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology (1993) 1.23
C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol (1990) 1.16
Immune-complex disease in guinea pig lungs. I. Elicitation by aerosol challenge, suppression with cobra venom factor, and passive transfer with serum. Clin Immunol Immunopathol (1977) 1.16
Augmentation of reverse arthus reaction by mast cells in mice. J Clin Invest (1991) 1.09
Immune complex injury of the lung. Symposium held at the 74th annual meeting of the American Thoracic Society, Las Vegas, Nevada, May 1979. Am Rev Respir Dis (1981) 1.08
Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology (1993) 1.06
Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur J Immunol (1996) 1.04
Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur J Immunol (1996) 1.00
The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology (1991) 0.97
Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol (1994) 0.91
Immunology. Drawing a double-edged sword. Nature (1994) 0.91
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature (1995) 5.15
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97
Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell (1994) 4.53
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature (1996) 4.41
Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell (1996) 3.91
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Obesity and inequities in health in the developing world. Int J Obes Relat Metab Disord (2004) 3.49
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
The chemotactic receptor for human C5a anaphylatoxin. Nature (1991) 3.15
Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res (1999) 2.81
Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus. Nature (1995) 2.75
Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med (1997) 2.75
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol (2001) 2.69
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) (1988) 2.64
A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature (1995) 2.58
C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol (1994) 2.57
HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem (1997) 2.55
Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann's organizer. Nature (1996) 2.54
Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol (2000) 2.49
Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell (1997) 2.44
Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A (1994) 2.41
The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J Neurosci (2000) 2.28
A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J Virol (1998) 2.28
Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci (1999) 2.26
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Neurogenic amplification of immune complex inflammation. Science (1996) 2.05
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol (1997) 2.04
BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development (2000) 2.02
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903. HIV Med (2006) 1.97
The ultimate speed of magnetic switching in granular recording media. Nature (2004) 1.89
CD4-independent binding of SIV gp120 to rhesus CCR5. Science (1997) 1.87
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem (2000) 1.80
Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant (2010) 1.74
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem (1994) 1.72
Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem (1981) 1.70
Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus. J Neurosci (1998) 1.63
The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol (1998) 1.63
AIDS vaccine development. Science (1998) 1.62
PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation. Nat Neurosci (2001) 1.62
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med (1998) 1.59
Effect of sterilization method and other modifications on the wear resistance of acetabular cups made of ultra-high molecular weight polyethylene. A hip-simulator study. J Bone Joint Surg Am (2000) 1.58
Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene (2009) 1.54
Neutral endopeptidase modulation of septic shock. J Exp Med (1995) 1.53
Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat Immunol (2001) 1.51
Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest (1997) 1.51
Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49
Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Endocrinology (2002) 1.48
The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr Opin Immunol (1994) 1.47
Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience (2004) 1.46
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ (2011) 1.42
Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics (1992) 1.42
Neurotrophins promote maturation of developing neuromuscular synapses. J Neurosci (1995) 1.41
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation (2005) 1.40
Endoderm induction by the organizer-secreted factors chordin and noggin in Xenopus animal caps. EMBO J (1996) 1.39
Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts. Am J Sports Med (1996) 1.38
A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem (1991) 1.38
Cleavage of tryptophanyl peptide bonds in cytochrome b5 by cyanogen bromide. J Biol Chem (1977) 1.38
Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol (2000) 1.37
Drosophila par-1 is required for oocyte differentiation and microtubule organization. Curr Biol (2001) 1.37
The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem (1992) 1.34